Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 125.56% | 561.68% | 520.87% | 251.15% | 0.67% |
| Total Other Revenue | 30.50% | 26.28% | 20.44% | 24.89% | 19.33% |
| Total Revenue | 53.45% | 68.06% | 41.81% | 32.05% | 9.70% |
| Cost of Revenue | 16.11% | 34.62% | 23.65% | 32.83% | 7.45% |
| Gross Profit | 79.91% | 91.78% | 54.10% | 31.52% | 11.35% |
| SG&A Expenses | 55.01% | 38.59% | 24.71% | 35.13% | 17.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.47% | 32.02% | 21.80% | 29.00% | 11.39% |
| Operating Income | -37.38% | -23.80% | -16.77% | -28.24% | -11.80% |
| Income Before Tax | -47.30% | -14.27% | 1.28% | -8.71% | 1.87% |
| Income Tax Expenses | 128.95% | 99.26% | 98.44% | -97.72% | -147.06% |
| Earnings from Continuing Operations | -48.27% | -14.82% | 0.84% | -7.60% | 3.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.27% | -14.82% | 0.84% | -7.60% | 3.50% |
| EBIT | -37.38% | -23.80% | -16.77% | -28.24% | -11.80% |
| EBITDA | -38.95% | -24.62% | -16.98% | -28.96% | -12.07% |
| EPS Basic | -20.22% | 4.40% | 14.86% | 3.73% | 10.95% |
| Normalized Basic EPS | -19.37% | 4.93% | 15.28% | -6.72% | 0.53% |
| EPS Diluted | -20.22% | 4.40% | 14.86% | 3.73% | 10.95% |
| Normalized Diluted EPS | -19.37% | 4.93% | 15.28% | -6.72% | 0.53% |
| Average Basic Shares Outstanding | 20.82% | 18.94% | 16.89% | 12.35% | 9.02% |
| Average Diluted Shares Outstanding | 20.82% | 18.94% | 16.89% | 12.35% | 9.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |